Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke
Pérez-Mato, M; Dopico-Lopez, A; Akkoc, Y; López-Amoedo, S; Correa-Paz, C; Candamo-Lourido, M; Iglesias-Rey, R; López-Arias, E; da Silva-Candal, A; Bravo, SB; Chantada-Vázquez, MD; Arias, S; Santamaría-Cadavid, M; Estany-Gestal, A; Zaghmi, A; Gauthier, MA; Gutierrez-Fernandez, M; Martin, A; Llop, J; Rodríguez, C; Almeida, A; Migliavacca, M; Polo, E; Pelaz, B; Gozuacik, D; El Yamani, N; SenGupta, T; Rundén-Pran, E; Vivancos, J; Castellanos, M; Díez-Tejedor, E; Sobrino, T; Rabinkov, A; Mirelman, D; Castillo, J; Campos, F
iScience, 2024, 27, 111108
Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy.
Choi, H; Jeong, SH; Simo, C; Bakenecker, A; Llop, J; Lee, HS; Kim, TY; Kwak, C; Koh, GY; Sanchez, S; Hahn, SK
Nat. Commun., 2024, 15, 9934
Positron Emission Tomography-Assisted Photothermal Therapy with Gold Nanorods
Renero-Lecuna, C; Pulagam, KR; Uribe, KB; Vázquez-Aristizabal, P; Gómez-Vallejo, V; Liz-Marzán, LM; Llop, J; Henriksen-Lacey, M
Part. Part. Syst. Charact., 2024, , 2400185
Alpha7 nicotinic receptors as potential theranostic targets for experimental stroke
Garbizu, M; Aguado, L; Martín, A
Neural Regen. Res., 2024, 19, 939-940
The In Vivo Biological Fate of Protein Corona: A Comparative PET Study of the Fate of Soft and Hard Protein Corona in Healthy Animal Models
Villacorta, AM; Mielcarek, A; Martinez, MG; Jorge, H; Henschke, A; Coy, E; Gomez-Vallejo, V; Llop, J; Moya, SE
Small, 2024, , e2309616
Lipidomics and biodistribution of extracellular vesicles-secreted by hepatocytes from Zucker lean and fatty rats
Azparren-Angulo, M; Mleczko, J; Alboniga, OE; Kruglik, S; Guigner, J; Gonzalez, E; Garcia-Vallicrosa, C; Llop, J; Simó, C; Alonso, C; Iruarrizaga, M; Royo, F; Falcon-Perez, JM.
J. Extracell. Biol., 2024, 3, e140
Synthesis and PET Imaging Biodistribution Studies of Radiolabeled Iododiflunisal, a Transthyretin Tetramer Stabilizer, Candidate Drug for Alzheimers Disease
Joshi, S.M.; Wilson, T.C.; Li, Z.; Preshlock, S.; Gomez-Vallejo, V.; Gouverneur, V.; Llop, J.; Arsequell, G.
Molecules, 2024,10.3390/molecules29020488
A study of complexation and biological fate of polyethyleneimine-siRNA polyplexes in vitro and in vivo by fluorescence correlation spectroscopy and positron emission tomography imaging
Ludtke, T; Simó, C; Reyes, SG; Moro, MM; Salvador, C; Ritacco, H; Andreozzi, P; Llop, J; Moya, SE
Nanoscale, 2024, 16, 3525-3533
Urease-powered nanobots for radionuclide bladder cancer therapy
Simó, C; Serra-Casablancas, M; Hortelao, AC; Di Carlo, V; Guallar-Garrido, S; Plaza-García, S; Rabanal, RM; Ramos-Cabrer, P; Yagüe, B; Aguado, L; Bardia, L; Tosi, S; Gómez-Vallejo, V; Martín, A; Patiño, T; Julián, E; Colombelli, J; Llop, J; Sánchez, S.
Nat. Nanotechnol., 2024, 19, 554-564
Anti-seizure effects of JNJ-54175446 in the intra-amygdala kainic acid model of drug-resistant temporal lobe epilepsy in mice
Mamad, O; Heiland, M; Lindner, AU; Hill, TDM; Ronroy, RM; Rentrup, K; Sanz-Rodriguez, A; Langa, E; Heller, JP; Moreno, O; Llop, J; Bhattacharya, A; Palmer, JA; Ceusters, M; Engel, T; Henshall, DC
Front. Pharmacol., 2024, 14, 1308478
A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET/CT imaging of triple-negative breast cancer.
Huang, W; Martinez, Maria Gomez; Emilia, H.; Jing, Q; Gomez-Vallejo, V.; Jorge Mendazona, H.; Jokivarsi, K.; Scaravilli, M.; Latonen, L.; Llop, J.; Lehto, V.; Xu, W

Int. J. Pharm., 2024, 652, 123764
Multimodal imaging of the role of hyperglycemia following experimental subarachnoid hemorrhage
Joya, A; Plaza-Garcia, S; Padro, D; Aguado, L; Iglesias, L; Garbizu, M; Gomez-Vallejo, V; Laredo, C; Cossio, U; Torne, R; Amaro, S; Planas, AM; Llop, J; Ramos-Cabrer, P; Justicia, C; Martin, A
J. Cereb. Blood Flow Metab., 2023, , 127070